Lynn A. Tetrault, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 19,593 shares at $44.62 ($875K) on 2024-08-12, disclosed to the SEC on 2024-08-14.
Scheduled sale ($875k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.62 | 9,593 | $428K | 48.9% |
| 2 | $44.62 | 9,593 | $428K | 48.9% |
| 3 | $45.37 | 407 | $18K | 2.1% |
| Total | $44.64 avg | 19,593 | $875K | 100% |
| Filing → |
| NEO | SELL | 2026-06-11 | $60K | — | Filing → |
| NEO | BUY | 2025-05-09 | $114K | — | Filing → |
| RYTM | SELL | 2024-09-11 | $2.0M | — | Filing → |